{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32241095", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "09"}, "DateRevised": {"Year": "2020", "Month": "11", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "04", "Day": "02"}], "ELocationID": ["3119", "10.4081/ejh.2020.3119"], "Journal": {"ISSN": "2038-8306", "JournalIssue": {"Volume": "64", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Apr", "Day": "02"}}, "Title": "European journal of histochemistry : EJH", "ISOAbbreviation": "Eur J Histochem"}, "ArticleTitle": "Ozone at low concentrations does not affect motility and proliferation of cancer cells in vitro.", "Abstract": {"AbstractText": ["Exposure to low ozone concentrations is used in medicine as an adjuvant/complementary treatment for a variety of diseases. The therapeutic potential of low ozone concentrations relies on their capability to increase the nuclear translocation of the Nuclear factor erythroid 2-related factor 2 (Nrf2), thus inducing the transcription of Antioxidant Response Elements (ARE)-driven genes and, through a cascade of events, a general cytoprotective response. However, based on the controversial role of Nrf2 in cancer initiation, progression and resistance to therapies, possible negative effects of ozone therapy may be hypothesised in oncological patients. With the aim to elucidate the possible changes in morphology, migration capability and proliferation of cancer cells following mild ozone exposure, we performed wound healing experiments in vitro on HeLa cells treated with low ozone concentrations currently used in the clinical practice. By combining a multimodal microscopy approach (light and fluorescence microscopy, scanning electron microscopy, atomic force microscopy) with morphometric analyses, we demonstrated that, under our experimental conditions, exposure to low ozone concentrations does not alter cytomorphology, motility and proliferation features, thus supporting the notion that ozone therapy should not positively affect tumour cell growth and metastasis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona. manuela.costanzo@univr.it."}], "LastName": "Costanzo", "ForeName": "Manuela", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Romeo", "ForeName": "Alessandro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cisterna", "ForeName": "Barbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Calderan", "ForeName": "Laura", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Bernardi", "ForeName": "Paolo", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Covi", "ForeName": "Viviana", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tabaracci", "ForeName": "Gabriele", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Malatesta", "ForeName": "Manuela", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Eur J Histochem", "NlmUniqueID": "9207930", "ISSNLinking": "1121-760X"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "HeLa Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}], "CoiStatement": "Conflict of interest: The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: The low dose ozone concept-guidelines and treatment strategies. Ozone Sci Eng 2012;34:408-24."}, {"Citation": "Gali\u00e8 M, Covi V, Tabaracci G, Malatesta M. The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int J Mol Sci. 2019;20pii:E4009.", "ArticleIdList": ["PMC6720777", "31426459"]}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med 2011;9:66.", "ArticleIdList": ["PMC3125221", "21575276"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Goldman M. Cancer risk of low-level exposure. Science 1996;271:1821-2.", "ArticleIdList": ["8596947"]}, {"Citation": "Furukawa M, Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3- Roc1 ligase. Mol Cell Biol 2005;25:162-71.", "ArticleIdList": ["PMC538799", "15601839"]}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, Belmonte G, Gardi C, Virgili F, et al. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol 2013;267:30-40.", "ArticleIdList": ["23253326"]}, {"Citation": "Re L, Mart\u00ednez-S\u00e1nchez G, Bordicchia M, Malcangi G, Pocognoli A, Morales-Segura MA, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol 2014;742:158-62.", "ArticleIdList": ["25218903"]}, {"Citation": "Valacchi G, Sticozzi C, Zanardi I, Belmonte G, Cervellati F, Bocci V, et al. Ozone mediators effect on \u201cin vitro\u201d scratch wound closure. Free Radic Res 2016;50:1022-31.", "ArticleIdList": ["27487012"]}, {"Citation": "Delgado-Roche L, Riera-Romo M, Mesta F, Hern\u00e1ndez-Matos Y, Barrios JM, Mart\u00ednez-S\u00e1nchez G, et al. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and proinflammatory cytokines in multiple sclerosis patients. Eur J Pharmacol 2017;811:148-54.", "ArticleIdList": ["28623000"]}, {"Citation": "Meng W, Xu Y, Li D, Zhu E, Deng L, Liu Z, et al. Ozone protects rat heart against ischemia-reperfusion injury: a role for oxidative preconditioning in attenuating mitochondrial injury. Biomed Pharmacother 2017;88,1090-97.", "ArticleIdList": ["28192883"]}, {"Citation": "Wang Z, Zhang A, Meng W, Wang T, Li D, Liu Z, et al. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur J Pharmacol 2018;835:82-93.", "ArticleIdList": ["30075224"]}, {"Citation": "Braidy N, Izadi M, Sureda A, Jonaidi-Jafari N, Banki A, Nabavi SF, et al. Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain. J Cell Physiol 2018;233:2705-14.", "ArticleIdList": ["28594115"]}, {"Citation": "Gali\u00e8 M, Costanzo M, Nodari A, Boschi F, Calderan L, Mannucci S, et al. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic Biol Med 2018;124:114-21.", "ArticleIdList": ["29864481"]}, {"Citation": "Borrelli E. Mechanism of action of oxygen ozone therapy in the treatment of disc herniation and low back pain. Acta Neurochir Suppl 2011;108:123-5.", "ArticleIdList": ["21107948"]}, {"Citation": "Muto M, Giurazza F, Silva RP, Guarnieri G. Rational approach, technique and selection criteria treating lumbar disk herniations by oxygen-ozone therapy. Interv Neuroradiol 2016;22:736-40.", "ArticleIdList": ["PMC5564357", "27485047"]}, {"Citation": "Lopes de Jesus CC, Dos Santos FC, de Jesus LMOB, Monteiro I, Sant\u2019Ana MSSC, Trevisani VFM. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study. PLoS One 2017;12:e0179185.", "ArticleIdList": ["PMC5524330", "28738079"]}, {"Citation": "Carpendale MT, Freeberg J, Griss JM. Does ozone alleviate AIDS diarrhea? J Clin Gastroenterol 1993;17:142-5.", "ArticleIdList": ["8409316"]}, {"Citation": "Altinel O, Demirbas S, Cakir E, Yaman H, Ozerhan I.H, Duran E, et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest 2011;71:185-92.", "ArticleIdList": ["21198421"]}, {"Citation": "Aslaner A, \u00c7ak\u0131r T, Tekeli S, Avc\u0131 S, Do\u011fan U, Tekeli F, et al. Medical ozone treatment ameliorates the acute distal colitis in rat. Acta Cir Bras 2016;31:256-63.", "ArticleIdList": ["27168538"]}, {"Citation": "Hern\u00e1ndez Rosales FA, Calunga Fern\u00e1ndez JL, Turrent Figueras J, Men\u00e9ndez Cepero S, Montenegro Perdomo A. Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 2005;36:549-54.", "ArticleIdList": ["16099337"]}, {"Citation": "Kucukgul A, Erdogan S, Gonenci R, Ozan G. Beneficial effects of nontoxic ozone on H2O2-induced stress and inflammation. Biochem Cell Biol 2016;94:577-83.", "ArticleIdList": ["27842206"]}, {"Citation": "Gupta G, Mansi B. Ozone therapy in periodontics. J Med Life 2012;5:59-67.", "ArticleIdList": ["PMC3307081", "22574088"]}, {"Citation": "Al-Omiri MK, Abul Hassan RS, AlZarea BK, Lynch E. Comparison of dental bleaching effects of ozone and hydrogen peroxide: An ex vivo study. Am J Dent 2016;29:251-4.", "ArticleIdList": ["29178736"]}, {"Citation": "Isler SC, Unsal B, Soysal F, Ozcan G, Peker E, Karaca IR. The effects of ozone therapy as an adjunct to the surgical treatment of peri-implantitis. J Periodontal Implant Sci 2018;48:136-51.", "ArticleIdList": ["PMC6031764", "29984044"]}, {"Citation": "Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Fo\u00e0 R. Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 2007;92:1289-90.", "ArticleIdList": ["17768133"]}, {"Citation": "Berni F, Bolletin A, Bonfatti A, Chiamenti L, De Belardini V, De Bonis T, et al. Effectiveness of oxygen-ozone therapy as support treatment in the care of cancer patients undergoing chemo/radiotherapy (Conference Paper). Int J Ozone Ther 2013;12:38-9."}, {"Citation": "Clavo B, Santana-Rodriguez N, Llontop P, Gutierrez D, Ceballos D, M\u00e9ndez C, et al. Ozone therapy in the management of persistent radiation-induced rectal bleeding in prostate cancer patients. Evid Based Complement Alternat Med 2015;2015:480369.", "ArticleIdList": ["PMC4556325", "26357522"]}, {"Citation": "Velikaya VV, Gribova OV, Musabaevau U, Startseva ZhA, Simonov KA, Aleinik AN, et al. Ozone therapy for radiation reactions and skin lesions after neutron therapy in patients with malignant tumors. Voprosy Onkologii 2015;61:571-4.", "ArticleIdList": ["26571824"]}, {"Citation": "Luongo M, Brigida AL, Mascolo L, Gaudino G. Possible therapeutic effects of ozone mixture on hypoxia in tumor development. Anticancer Res 2017;37:425-35.", "ArticleIdList": ["28179287"]}, {"Citation": "DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011;475:106-9.", "ArticleIdList": ["PMC3404470", "21734707"]}, {"Citation": "Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012;22:66-79.", "ArticleIdList": ["22789539"]}, {"Citation": "Chio II, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 2016;166: 963-76.", "ArticleIdList": ["PMC5234705", "27477511"]}, {"Citation": "Hojo T, Maishi N, Towfik AM, Akiyama K, Ohga N, Shindoh M, et al. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells. Oncotarget 2017; 8:45484-95.", "ArticleIdList": ["PMC5542202", "28525375"]}, {"Citation": "Kang KA, Hyun JW. Oxidative stress, Nrf2, and epigenetic modification contribute to anticancer drug resistance. Toxicol Res 2017; 33:1-5.", "ArticleIdList": ["PMC5266370", "28133507"]}, {"Citation": "Clavo B, Santana-Rodr\u00edguez N, Llontop P, Guti\u00e9rrez D, Su\u00e1rez G, L\u00f3pez L, et al. Ozone therapy as adjuvant for cancer treatment: Is further research warranted? Evid Based Complement Alternat Med 2018;2018:7931849.", "ArticleIdList": ["PMC6151231", "30271455"]}, {"Citation": "Tirelli U, Cirrito C, Pavanello M, Del Pup L, Lleshi A, Berretta M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue - A short report. Eur Rev Med Pharmacol Sci 2018;22:8030-3.", "ArticleIdList": ["30536352"]}, {"Citation": "Jonkman JEN, Cathcart JA, Xu F, Bartolini ME, Amon JE, Stevens KM, et al. An introduction to the wound healing assay using live-cell microscopy. Cell Adh Migr 2014;8:440-51.", "ArticleIdList": ["PMC5154238", "25482647"]}, {"Citation": "Costanzo M, Cisterna B, Vella A, Cestari T, Covi V, Tabaracci G, et al. Low ozone concentrations stimulate cytoskeletal organization, mitochondrial activity and nuclear transcription. Eur J Histochem 2015;59:2515.", "ArticleIdList": ["PMC4503975", "26150162"]}, {"Citation": "Costanzo M, Cisterna B, Covi V, Tabaracci G, Malatesta M.\nAn easy and inexpensive method to expose adhering cultured cells to ozonization. Microscopie\n2015;23:46-52. Available from: https://www.pagepressjournals.org/index.php/microscopie/article/view/5164"}, {"Citation": "Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Gary Borisy G, et al. Cell Migration: Integrating Signals from Front to Back. Science 2003;302:1704-9.", "ArticleIdList": ["14657486"]}, {"Citation": "Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol 2014;171:5507-23.", "ArticleIdList": ["PMC4290699", "24665826"]}, {"Citation": "Huang CH, Tang M, Shi C, Iglesias PA, Devreotes PN. An excitable signal integrator couples to an idling cytoskeletal oscillator to drive cell migration. Nat Cell Biol 2013;15:1307-16.", "ArticleIdList": ["PMC3838899", "24142103"]}, {"Citation": "Sakai J, Li J, Subramanian KK, Mondal S, Bajrami B, Hattori H, et al. Reactive oxygen species (ROS)-induced actin glutathionylation controls actin dynamics in neutrophils. Immunity 2012;37:1037-49.", "ArticleIdList": ["PMC3525814", "23159440"]}, {"Citation": "Taulet N, Delorme-Walker VD, DerMardirossian C. Reactive oxygen species regulate protrusion efficiency by controlling actin dynamics. PLoS ONE 2012;7:e41342.", "ArticleIdList": ["PMC3410878", "22876286"]}, {"Citation": "Muliyil S, Narasimha M. Mitochondrial ROS regulates cytoskeletal and mitochondrial remodeling to tune cell and tissue dynamics in a model for wound healing. Dev Cell 2014;28:239-52.", "ArticleIdList": ["24486154"]}, {"Citation": "Kloska D, Kopacz A, Cysewski D, Aepfelbacher M, Dulak J, Jozkowicz A, et al. Nrf2 sequesters Keap1 preventing podosome disassembly: a quintessential duet moonlights in endothelium. Antioxid Redox Signal 2019;30:1709-30.", "ArticleIdList": ["30198307"]}, {"Citation": "Paterson EK, Courtneidge SA. Invadosomes are coming: new insights into function and disease relevance. FEBS J 2018;285:8-27.", "ArticleIdList": ["PMC6029861", "28548369"]}, {"Citation": "Rachakonda G, Sekhar KR, Jowhar D, Samson PC, Wikswo JP, Beauchamp RD, et al. Increased cell migration and plasticity in Nrf2-deficient cancer cell lines. Oncogene 2010;29: 3703-14.", "ArticleIdList": ["PMC2892014", "20440267"]}, {"Citation": "Chien MH, Lee WJ, Hsieh FK, Li CF, Cheng TY, Wang MY, et al. Keap1-Nrf2 interaction suppresses cell motility in lung adenocarcinomas by targeting the s100p protein. Clin Cancer Res 2015;21:4719-32.", "ArticleIdList": ["26078391"]}, {"Citation": "Tertil M, Golda S, Skrzypek K, Florczyk U, Weglarczyk K, Kotlinowski J, et al. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: antitumoral effects associated with down-regulation of matrix metalloproteinases. Free Radic Biol Med 2015;89:147-57.", "ArticleIdList": ["26393425"]}, {"Citation": "Xue D, Zhou C, Shi Y, Lu H, Xu R, He X. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin. Oncotarget 2016;7:78804-12.", "ArticleIdList": ["PMC5346678", "27788496"]}, {"Citation": "Scassellati C, Costanzo M, Cisterna B, Nodari A, Gali\u00e8 M, Cattaneo A, et al. Effects of mild ozonisation on gene expression and nuclear domains organization in vitro. Toxicol In Vitro 2017;44:100-10.", "ArticleIdList": ["28652203"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "2", "Day": "23"}, {"Year": "2020", "Month": "3", "Day": "19"}, {"Year": "2020", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["32241095", "PMC7137928", "10.4081/ejh.2020.3119"]}}], "PubmedBookArticle": []}